In the present study, we have used TRBV-seq of MS brain lesions with different location and inflammatory activity and paired circulating memory CD4+ and CD8+ T cells to identify putatively pathogenic T cells and to address a number of important questions such as how lesion location or inflammatory activity influence brain-infiltrating TRBV repertoires, whether brain infiltrates are primarily CD4+ or CD8+ T cell-derived, and how brain-infiltrating T cells are represented in the peripheral memory T cell compartments. This evidence concerns the gene CD4 and myeloid sarcoma.